The potential management of resistant infections with non-antibiotics

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 3, 1997, Pages 319-327

  Kristiansen, Jette Elisabeth ^a   Amaral, Leonard ^a  

^a Department of Clinical Microbiology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; CALCIUM ANTAGONIST; DIURETIC AGENT; LOCAL ANESTHETIC AGENT; MUCOLYTIC AGENT; NEUROTROPIC AGENT; PHENOTHIAZINE DERIVATIVE; PROTON PUMP INHIBITOR;

ANTIBACTERIAL ACTIVITY; BACTERIAL INFECTION; DRUG MECHANISM; DRUG POTENTIATION; REVIEW; TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; ANTIPSYCHOTIC AGENTS; BACTERIAL INFECTIONS; CALCIUM CHANNEL BLOCKERS; DRUG RESISTANCE, MICROBIAL; DRUG SYNERGISM; HISTAMINE H1 ANTAGONISTS; HUMANS; LACTAMS; PHENOTHIAZINES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0030801767     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.3.319     Document Type: Review

References (48)

1. Kristiansen, J. E. (1990). The antimicrobial activity of psychotherapeutic drugs and stereo-isomeric analogues. (Thesis, DMSC). Danish Medical Bulletin 37, 165-82.
2. Kristiansen, J. E. (1991). Antimicrobial activity of non-antibiotics. ASM NEWS 57, 135-9.
3. Kristiansen, J. E. (1992). Antimicrobial activity of non-antibiotics. Reports from a congress on the antimicrobial effect of drugs other than antibiotics on bacteria, viruses, protozoa, and other organisms. Copenhagen, May, 1990. Acta Pathology Microbiology et Immunology Scandinavia (APMIS), Suppl. 100, 7-14.
4. Cederlund, H. & Mårdh, P. A. (1993). Antibacterial activities of non-antibiotic drugs. Journal of Antimicrobial Chemotherapy 32, 355-65.
5. Williams, J. D. (1995). Selective toxicity and concordant pharmacodynamics of antibiotics and other drugs. Journal of Antimicrobial Chemotherapy 35, 721-37.
6. Kristiansen, J. E., Andersen, L. P., Vestergaard, B. F. & Hvidberg, E. F. (1991). Effect of selected neuroleptic agents and stereo-isomeric analogues on virus and eukaryotic cells. Pharmacology & Toxicology 68, 399-403.
7. Gerber, H. R. & Anton, A. H. (1974). A bacterial model for the evaluation of barbiturates. Archives Internationales Pharmacodynamie et Therapie 212, 284-96.
8. Schmidt, R. M. & Rosenkranz, H. S. (1970). Antimicrobial activity of local anaesthetics: lidocaine and procaine. Journal of Infectious Disease 121, 596-607.
9. Kristiansen, J. E., Mortensen, I. & Nissen, B. (1982). Membrane stabilizers inhibit potassium efflux from Staphylococcus aureus strain no. U 2275. Biochimica et Biophysica Acta 685, 379-82.
10. Kramer, A., Sorgatz, K., Höppe, H. & Meyer, F. U. (1994). Bacteriostatic and antiseptic efficacy of selected anaesthetics individually and in combination with an antiseptic mouthwash. Hygiene Medizin 19, 527-34.
11. Takahashi, N., Murota, H. & Sutoh, I. (1983). Antimicrobial activity of topical beta-adrenergic blocking agents. Ophthalmic Research 15, 277-9.
12. Dastidar, S. G., Mondai, U., Niyogi, S. & Chakrabarty, A. N. (1986). Antibacterial property of methyl-DOPA and development of antibiotic cross-resistances in m-DOPA mutants. Indian Journal of Medical Research 84, 142-7.
13. Giunta, S., Galeazzi, L., Turchetti, G., Sampaoli, G. & Groppa, G. (1985). In vitro antistreptococcal activity of the potassium-sparing diuretics amiloride and triamterene. Antimicrobial Agents and Chemotherapy 28, 419-20.
14. Domenico, P., Schwartz, S. & Cunha, B. A. (1989). Reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate. Infection and Immunity 57, 3778-82.
15. Parry, M. F. & Neu, H. C. (1977). Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. Journal of Clinical Microbiology 5, 58-61.
16. Amaral, L. & Lorian, V. (1991). Effects of chlorpromazine on the cell envelope proteins of Escherichia coli. Antimicrobial Agents and Chemotherapy 35, 1923-4.
17. Amaral, L., Kristiansen, J. E. & Lorian, V. (1992). Synergic effect of chlorpromazine on the activity of some antibiotics. Journal of Antimicrobial Chemotherapy 30, 556-8.
18. Kristiansen, J. E. H. (1993). Chlorpromazine: non-antibiotics with antimicrobial activity - new insights in managing resistance? Current Opinion in Investigational Drugs 2, 587-91.
19. Kristiansen, J. E., Amaral, L. & Thomsen, V. F. (1993). The reversal of antibiotic resistance by phenothiazines. In Abstract 18th International Congress of Chemotherapy. Stockholm, Sweden. Abstract 510, p. 65.
20. Amaral, L., Kristiansen, J. E. & Thomsen, V. F. (1993). The effect of chlorpromazine on the cell envelope of sensitive and resistant bacteria. In Abstract of the 18th International Congress of Chemotherapy. Stockholm, Sweden. Abstract 493 p. 65.
21. Manion, R. E., Bradley, S. G. & Hall, W. H. (1969). Retardation of the emergence of isoniazid-resistant mycobacteria by phenothiazines and quinacrine. Proceedings of the Society of Experimental Biology and Medicine 130, 206-9.
22. Amaral, L., Kristiansen, J. E., Abebe, L. & Millett, W. (1997). Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis. Journal of Antimicrobial Chemotherapy 38, 1049-53.
23. Ehrlich, P. (1956). Über die Methylenblaureaction der lebenden Nervensubstanz. In The collected papers of Paul Ehrlich III (Himmelweit, F., Marquardt, M. & Dale, H., Eds), pp. 500-8. Pergamon Press, London. (Reprinted from Deutsche Medizinische Wochenschrift 1886).
24. Kristiansen, J. E. H. (1977). Fatal chloroquin poisoning with severe hypokalaemia. Ugeskrift for Læger 139, 1666-7.
25. Molnàr, J., Ren, J., Kristiansen, J. E. & Nakamura, M. J. (1992). Effects of some tricyclic psychopharmacons and structurally related compounds on motility of Proteus vulgaris. Antonie van Leeuwenhoek 62, 315-20.
26. Guttmann, P. & Ehrlich, P. (1891). Über die Wirkung des Methylenblau bei Malaria. Berliner Klinische Wochenschrift 39, 953-6.
27. Molnàr, J., Haszon, I., Bodrogi, T., Martonyi, E. & Turi, S. (1990). Synergistic effect of promethazine with gentamycin in frequently recurring pyelonephritis. International Journal of Urology and Nephrology 22, 405-11.
28. Garrod, L. P., Lambert, H. P., O'Grady, F. & Waterworth, P. M. (1981). Antibiotics and Chemotherapy, 5th edn. Churchill Livingstone, Edinburgh.
29. Neu, H. C. (1994). 1934-1994. Antimicrobial chemotherapy. Antimicrobics and Infectious Diseases Newsletter 13, 1-8.
30. Mayer, K. H., Opal, S. M. & Medeiros, A. (1990). Mechanisms of antibiotic resistance. In Principles and Practice of Infectious Diseases, 3rd edn (Mandell, G. L., Douglas, R. G., Bennett, J. E., Eds), pp. 218-28. Churchill Livingstone, New York.
31. Elipoulos, G. M. & Moellering, R. C. (1980). (Chapter 13) Antimicrobial Combinations In Antibiotics in Laboratory Medicine (Lorian, V., Ed.), pp. 432-480. Williams and Wilkins, Baltimore, MD.
32. Acar, J. F., Goldstein, F. & Chabbart, Y. A. (1973). Synergistic activity of trimethroprim-sulfamethoxazole on Gram-negative bacilli: observations in vitro and in vivo. Journal of Infectious Diseases 128, Suppl., 470-7.
33. Gutschik, E. (1984). Experimentel endocarditis. Lægeforeningens forlag. Thesis, University of Copenhagen, Denmark.
34. Nicolau, D. P., Marangos, M. N., Nightingale, C. H. & Quintiliani, R. (1995). Influence of aspirin on development and treatment of experimental Staphyloccocus aureus endocarditis. Antimicrobial Agents and Chemotherapy 39, 1748-51.
35. Ehrlich, P. (1913). Chemotherapeutics: scientific principles, methods and results. Lancet ii, 445-51.
36. Chattopadhyay, D., Dastidar, S. G. & Chakrabarty, A. N. (1987). Determination of in vitro antibacterial activity of methdilazine, an antihistamine, and its synergism with aminoglycoside antibiotics. Indian Journal Medical Microbiology, 5, 171-7.
37. Sevag, M. G. (1964). Prevention of the emergence of antibiotic resistant strains of bacteria by atabrine. Archives of Biochemistry and Biophysics 108, 85-8.
38. Heller, C. S. & Sevag, M. G. (1966). Prevention of the emergence of drug resistance in bacteria by acridines, phenothiazines, and dibenzocyclheptenes. Applied Microbiology 14, 879-85.
39. Roberts, D. & Cole, P. (1981). N-Acetylcysteine potentiates the anti-pseudomonas activity of carbenicillin in vitro. Journal of Infection 3, 353-9.
40. Cohn, R. C., Jacobs, M. & Aronoff, S. C. (1988). In vitro activity of amiloride combined with tobramycin against pseudomonas isolates from patients with cystic fibrosis. Antimicrobial Agents and Chemotherapy 32, 395-6.
41. Walter, A. M. & Heilmeyer, L. (1965). Wirkungsbereich und Wirkungsweise der Penicilline. In Antibiotika-Fibel, Antibiotika und Chemotherapie, pp. 117-29. Georg Thieme Verlag, Stuttgart.
42. Amaral, L., Lee, Y., Schwarz, U. & Lorian, V. (1986). Penicillin-binding site on the Escherichia coli cell envelope. Journal of Bacteriology 167, 492-5.
43. Molnàr, J. (1984). Antibacterial and antiplasmid action of phenothiazines and structurally related compounds. D.Sc. Thesis, Hungarian Academy of Sciences, Budapest.
44. Kristiansen, J. E., Amaral, L. & Thomson, V. F. (1993). The effect of chlorpromazine on the ultrastructure of sensitive and resistant bacteria. In Abstracts of the 18th International Congress of Chemotherapy, Stockholm, Sweden, Abstract 492, p. 65.
45. Gemmel, C. G. & Lorian, V. (1991). Effects of low antibiotic concentrations on bacteria: effect on ultrastructure. Their virulence, and susceptibility to immunodefences: clinical significance (Chapter 10). In Antibiotics in Laboratory Medicine, 2nd edn (Lorian, V., Ed.), pp. 397-452. Williams & Wilkins, Baltimore, MD.
46. Levy, S. B. (1992). Active efflux mechanisms for antimicrobial resistance. Antimicrobial Agents and Chemotherapy 36, 695-703.
47. Forrest, F. M., Forrest, I. S. & Roizin, L. E. (1963). Clinical, biochemical and post-mortem studies on a patient treated with chlorpromazine. Revue Agressologie 3, 259-64.
48. Crowle, A. J., Douvas, G. S. & May, M. H. (1992). Chlorpromazine: a drug potentially useful for treating mycobacterial infections. Experimental Chemotherapy 38, 410-9.